Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04993885
What this trial is testing

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune ThrombocytopeniaAutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 52
Testing effectiveness (Phase 2)UnknownNCT04703621
What this trial is testing

The DART Study- Daratumumab Treatment in ITP

Who this might be right for
ITP
Ostfold Hospital Trust 21
Early research (Phase 1)Looking for participantsNCT04323748
What this trial is testing

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
New York Medical College 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Not applicableUnknownNCT03975361
What this trial is testing

Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)

Who this might be right for
Immune Thrombocytopenia (ITP)Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 10
Not applicableNot Yet RecruitingNCT06873672
What this trial is testing

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Who this might be right for
Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia Childhood+3 more
RenJi Hospital 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Not applicableAvailableNCT04837703
What this trial is testing

Managed Access Programs for ETB115, Eltrombopag

Who this might be right for
Thrombocytopenia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT04516837
What this trial is testing

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)UnknownNCT05302024
What this trial is testing

Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 100
Not applicableLooking for participantsNCT06715215
What this trial is testing

Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Sohag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06531018
What this trial is testing

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

Who this might be right for
Primary Immune Thrombocytopenia
Renata PLC 100
Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313
Testing effectiveness (Phase 2)Study completedNCT04278924
What this trial is testing

TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Takeda 41
Large-scale testing (Phase 3)Study completedNCT04188379
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Who this might be right for
Primary Immune Thrombocytopenia
argenx 131
Large-scale testing (Phase 3)UnknownNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Not applicableLooking for participantsNCT06556888
What this trial is testing

Observatory of Immunological Thrombopenic Purpura in the Brest Region

Who this might be right for
Immune Thrombocytopenia
University Hospital, Brest 500
Not applicableNot Yet RecruitingNCT07059910
What this trial is testing

Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

Who this might be right for
Immune Thrombocytopenic PurpuraThyroid Disorders
Assiut University 100
Not applicableUnknownNCT03998059
What this trial is testing

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Who this might be right for
ThrombocytopeniaSplenectomy
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableUnknownNCT05654766
What this trial is testing

Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies

Who this might be right for
Immune ThrombocytopeniaThrombocytopathyAcute Leukemia+1 more
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 200
Next Page